Cabex(Cabergoline) 0.5mg – 10 tablets EB

Description Cabex (Cabergoline) is a synthetic ergoline-based dopamine D2 receptor agonist with high affinity and long-lasting effects. It has been extensively studied for its ability to suppress prolactin secretion by acting directly on dopamine receptors in the anterior pituitary gland. This mechanism makes it relevant in research related to hyperprolactinemia, reproductive hormone regulation, and endocrine balance. In experimental contexts, cabergoline has also been explored for its neuroprotective properties, potential to influence mood and motivation, and its regulatory role in dopaminergic systems. Due to its long half-life and strong receptor selectivity, it allows for infrequent dosing while maintaining stable plasma levels. Additionally, cabergoline has been used in research investigating conditions such as Parkinson’s disease, where dopaminergic signaling plays a central role. The 0.5 mg oral tablet formulation supports controlled administration in various hormonal and neurological research protocols.